Lactate Levels: A Quick & Easy Test for People with HIV?
"New research explores a portable lactate analyzer for monitoring CSF and plasma, offering a potential solution for early detection of metabolic issues."
For people living with HIV, managing their health involves a complex balancing act. Antiretroviral therapy (ART) has significantly improved lives, but some medications, particularly nucleoside reverse transcriptase inhibitors (NRTIs), can cause mitochondrial dysfunction, leading to increased lactate levels.
High lactate levels can indicate metabolic disorders and other health problems. Monitoring lactate is crucial, but traditional lab tests can be slow, expensive, and not always accessible. What if there was a faster, easier way to keep track of lactate levels? Recent research investigates a portable lactate analyzer as a potential solution.
This article dives into a study comparing a portable lactate analyzer with a standard laboratory device for measuring lactate in cerebrospinal fluid (CSF) and plasma. We'll explore the accuracy, benefits, and potential implications of this technology for people with HIV.
Plasma Lactate as a Clinical Signal
Increased plasma lactate levels can indicate the presence of metabolic disorders in people infected with HIV. The cited method-comparison study evaluated a portable lactate analyzer for measuring lactate in cerebrospinal fluid and plasma. This positions lactate measurement as a potential tool for identifying metabolic concerns, while the study's focus on method comparison underscores the importance of assessing how portable measurements perform against accepted testing approaches.
From Laboratory Testing to Portable Monitoring
Lactate monitoring has applications in human healthcare, biotechnology, the food industry, and sports medicine. Traditional laboratory methods generally require invasive blood collection with needles and are described as costly and time-consuming. More recent portable and wearable technologies aim to make lactate measurement more accessible, including devices used for athletic performance monitoring, clinical diagnostics, and metabolic health assessment.
The Promise of Point-of-Care Testing: Is a Portable Analyzer the Answer?
The study, conducted at the University of California, San Diego, involved 178 participants, both HIV-positive and HIV-negative. Researchers collected CSF and plasma samples and tested them using both the Accutrend® Lactate portable analyzer and a reference laboratory device (SYNCHRON LX® 20). The goal was to see how well the portable analyzer measured up against the gold standard.
- Plasma: The portable analyzer was highly sensitive (95%) and specific (87%) in detecting abnormal lactate levels.
- CSF: The analyzer was highly specific (95%) but had lower sensitivity (33%). However, it was excellent at identifying normal lactate levels (95% negative predictive value).
Current Evidence on Portable Analyzers
A 2014 publication reported that increased plasma lactate can indicate metabolic disorders in HIV-infected individuals. A 2026 systematic review identified concerns about portable blood lactate analyzers, including variability in device accuracy, sampling procedures, and calibration. A 2026 comparison of Lactate Pro 2, Lactate Plus, and Lactate Scout 4 further examined accuracy, strip cost, app support, and intended use, illustrating that portable analyzers differ in practical and technical characteristics.
Accuracy Requires Caution
Portable blood lactate analyzers may be practical in non-clinical settings such as sports performance monitoring and education, but claims about their validity or reliability should be qualified. Reported concerns include variability in device accuracy, sampling procedures, and calibration. A separate study specifically investigated whether a portable analyzer was valid for measuring cerebrospinal fluid and plasma lactate in HIV-infected individuals, showing that validation is a central issue rather than an assumption.
Empowering People with HIV: The Future of Lactate Monitoring
The study highlights the potential of portable lactate analyzers for point-of-care testing, especially in settings with limited access to traditional labs. The Accutrend® Lactate offers a faster, more convenient way to monitor lactate levels, empowering individuals and healthcare providers to detect potential problems early.
Convenience Does Not Ensure Interchangeability
The handheld Lactate Express tracked overall responses well in the cited validation study. However, it showed concentration-dependent bias, which limited interchangeability with a laboratory reference for precise threshold-based exercise testing. The finding supports a balanced interpretation of portable lactate testing: handheld devices may capture broad response patterns while still differing from laboratory methods when precise thresholds matter.
A Growing Monitoring Market
The global lactate monitoring devices market was valued at USD 330.1 million in 2025, according to the cited market report. It is projected to grow from USD 352.3 million in 2026 to USD 538.0 million by 2034, with a projected CAGR of 5.4%. The listed future applications for handheld analyzers include telemedicine, remote monitoring, and personalized health management, while lactate analyzer products span portable and laboratory-based devices measuring lactate in blood, sweat, or saliva.
Moving Beyond Conventional Enzymatic Testing
Current lactate analysis often relies on enzymatic methods used in clinical analyzers and point-of-care testing devices. A 2026 report described a point-of-care testing platform for non-enzymatic lactate measurement, indicating ongoing efforts to develop alternative approaches. A separate 2024 review addressed non-invasive sensors designed for continuous lactate monitoring in critical-care patients, highlighting the challenge of making monitoring both continuous and less invasive.
Point-of-Care Testing in Practice
Point-of-care devices are described as providing simple, accurate serum lactate measurements at relatively low cost. The cited study assessed agreement between the portable Accutrend handheld lactate analyzer and a conventional laboratory system. It evaluated 82 adults receiving combination antiretroviral therapy who were considered at risk, testing their lactate levels in parallel with both modalities.
While further research is needed, particularly to improve the sensitivity for detecting elevated CSF lactate levels, this technology offers a promising step forward in managing the health of people living with HIV.
The ease of use and affordability of portable analyzers could lead to more frequent monitoring, earlier detection of metabolic issues, and ultimately, better health outcomes for people on antiretroviral therapy.